# HeartMate 3™ CE Mark Clinical Investigation Plan

> **NCT02170363** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 50 (actual)

## Conditions studied

- Advanced Refractory Left Ventricular Heart Failure

## Interventions

- **DEVICE:** Left Ventricular Assist System (LVAS)

## Key facts

- **NCT ID:** NCT02170363
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-05
- **Final completion:** 2020-03-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-06-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02170363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02170363, "HeartMate 3™ CE Mark Clinical Investigation Plan". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02170363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*